FISHER SCIENTIFIC BIOTECH LINE ApS
CVR 20940778 · Private limited company (ApS) · Active · Low risk
FISHER SCIENTIFIC BIOTECH LINE ApS is a Private limited company (ApS), founded on , based in Roskilde. The company is registered in the industry engroshandel med andre maskiner og andet udstyr. Our model estimates a bankruptcy risk of 0.3% over the next 12 months, which is 0.2 times the average for Danish companies. 20 annual reports have been published, of which 7 more than six months after the end of the financial year. The latest annual report (31 Dec 2025) shows equity of DKK 21.0m and a net result of DKK 6.9m. CEO: Arabella Lucy Mary Von Habsburg Lothringen.
Bankruptcy risk for FISHER SCIENTIFIC BIOTECH LINE ApS
0.2 × the average (1.41%) · higher risk than 56% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 20940778
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (28 years)
- Address
- Kamstrupvej 91
4000 Roskilde - Municipality
- Roskilde
- Industry
- Engroshandel med andre maskiner og andet udstyr (466400)
Bankruptcies in the industry: Engroshandel med andre maskiner og andet udstyr - Share capital
- DKK 502k
- Employees
- 12 (2018)
- Auditor
- PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB
- Audit opted out
- No
Warning signs
| Annual reports filed late | 12 of 27 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 32.3% |
| Current ratio | 148% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 16 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 0 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Gross profit | DKK 20.5m | DKK 22.0m | DKK 23.4m |
| Net profit | DKK 6.9m | DKK 22.5bn | DKK 8.0m |
| Equity | DKK 21.0m | DKK 14.1m | DKK 12.3bn |
| Total assets | DKK 65.2m | DKK 79.2m | DKK 12.4bn |
| Cash | DKK 16k | DKK 50k | – |
| Short-term debt | DKK 44.2m | DKK 65.1m | – |
| Avg. employees | 11 | 12 | – |
Latest annual report: Reporting class C, mellemstor virksomhed · auditor's statement: Revisionspåtegning · PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 215 | Late | |
| 1 Jan 2024 – 31 Dec 2024 | 192 | Late | |
| 1 Jan 2023 – 31 Dec 2023 | 193 | Late | |
| 1 Jan 2022 – 31 Dec 2022 | 184 | Late | |
| 1 Jan 2021 – 31 Dec 2021 | 199 | Late | |
| 1 Jan 2020 – 31 Dec 2020 | 181 | ||
| 1 Jan 2019 – 31 Dec 2019 | 148 | ||
| 1 Jan 2018 – 31 Dec 2018 | 155 | ||
| 1 Jan 2017 – 31 Dec 2017 | 157 | ||
| 1 Jan 2016 – 31 Dec 2016 | 153 | ||
| 1 Jan 2015 – 31 Dec 2015 | 162 | ||
| 1 Jan 2014 – 31 Dec 2014 | 167 | ||
| 1 Jan 2013 – 31 Dec 2013 | 174 | ||
| 1 Jan 2012 – 31 Dec 2012 | 276 | Late | |
| 1 Jan 2011 – 31 Dec 2011 | 165 | ||
| 1 Jan 2010 – 31 Dec 2010 | 153 | ||
| 1 Jan 2009 – 31 Dec 2009 | 147 | ||
| 1 Jan 2008 – 31 Dec 2008 | 160 | ||
| 1 Jan 2007 – 31 Dec 2007 | 153 | ||
| 1 Jan 2006 – 31 Dec 2006 | 291 | Late |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Arabella Lucy Mary Von Habsburg Lothringen | Current | |
| CEO | Jan Buch Andersen | ||
| CEO | Jan Buch Andersen | ||
| CEO | Guy Allan Fardell | ||
| CEO | Kim Søren Bidsted | ||
| CEO | Lisa Hagen | ||
| CEO | Nikolaj Schmølker | ||
| CEO | Peter Axel Sandberg | ||
| CEO | Thomas Arthur Nicholson | ||
| CEO | Carolin Sonja Vanscheidt Freidel | ||
| Board | Petrus Thomas Adrianus van der Zande | Current | |
| Board | Richard Lawrence Spoor | Current | |
| Board | Arabella Lucy Mary Von Habsburg Lothringen | Current | |
| Board | Jan Buch Andersen | ||
| Board | Kirsten Junker | ||
| Board | Guy Fardell | ||
| Board | Peter Axel Sandberg | ||
| Board | Ulla Christina Fardell | ||
| Board | John Anthony Dellapa | ||
| Board | Sylvia White | ||
| Board | Paul Matthew Meister | ||
| Board | Chetan Praful Mehta | ||
| Board | Michael Kenneth Michaud | ||
| Board | Pierre Francois Block | ||
| Board | Grant Hellier Lawrence | ||
| Board | Peter Axel Sandberg | ||
| Board | Dean Andrew Read | ||
| Board | Thomas Arthur Nicholson | ||
| Board | Monica Del Carmen Manotas Urueta | ||
| Board | Bo Kühnel Matthisson | ||
| Board | Carolin Sonja Vanscheidt Freidel | ||
| Owner (100%) | Perbio Science Sweden Holdings AB | Current | |
| Auditor | PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB | Current | |
| Auditor | inforevision statsautoriseret revisionsaktieselskab | ||
| Auditor | inforevision statsautoriseret revisionsaktieselskab | ||
| Auditor | PRICEWATERHOUSECOOPERS SERVICES STATSAUTORISERET REVISIONSAKTIESELSKAB | ||
| Auditor | DELOITTE HOLDING STATSAUTORISERET REVISIONSAKTIESELSKAB | ||
| Auditor | DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB | ||
| Founder | Jan Buch Andersen | Current | |
| Founder | Jan Buch Andersen |
The CEOs' other companies
Jan Buch Andersen – 7 other companies, of which 1 bankrupt
- BIOTECH ASSIST ApS Bankrupt 9 Nov 2020
- CLLUONE DIAGNOSTICS A/S Opløst
- CLLUONE THERAPEUTICS A/S Opløst
- INMOLD A/S Active
- L90 A/S Opløst
- MEDIC ADVICE ApS Opløst
- PENTABASE A/S Active
Kim Søren Bidsted – 4 other companies
- EXFLOW A/S Opløst
- IVUS Medical ApS Active
- Musiks ApS Active
- NordicEdge Partners ApS Active
Lisa Hagen – 1 other companies
- SERVICE CENTRALEN A/S Active
Address history (4 moves)
| Kamstrupvej 91, 4000 Roskilde | |
| Kamstrupvej 91, 4000 Roskilde | |
| c/o BIOTECHLINE A/S, Industrivej 3, 3550 Slangerup | |
| c/o BIOTECHLINE A/S, Industrivej 3, 3550 Slangerup | |
| Mejeribakken 1, 3540 Lynge |
Former names
| FISHER SCIENTIFIC BIOTECH LINE ApS | – now |
| FISHER SCIENTIFIC BIOTECH LINE A/S | – |
| BIOTECH LINE A/S | – |
Employees per year
Similar companies in Roskilde
- SEEPEX NORDIC A/S Roskilde
- BAADER DANMARK A/S Roskilde
- MÜLLER MARTINI Nordic A/S Jyllinge
- Kuhner Shaker ApS Roskilde
- Lafa Components ApS Jyllinge
- Dinautomat ApS Roskilde
- AltiCar ApS Havdrup
- IMS Robotics Nordic A/S Gadstrup
- Greenier ApS Roskilde
- API Solutions ApS Roskilde
- iMakr Nordic ApS Roskilde
- TeleTech A/S Roskilde
Questions and answers about FISHER SCIENTIFIC BIOTECH LINE ApS
Has FISHER SCIENTIFIC BIOTECH LINE ApS gone bankrupt?
No, FISHER SCIENTIFIC BIOTECH LINE ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of FISHER SCIENTIFIC BIOTECH LINE ApS?
Our model estimates a bankruptcy risk of 0.3% over the next 12 months (low risk), which is 0.2 times the average for Danish companies.
Who is the CEO of FISHER SCIENTIFIC BIOTECH LINE ApS?
Arabella Lucy Mary Von Habsburg Lothringen is the CEO of FISHER SCIENTIFIC BIOTECH LINE ApS.
Who is the auditor of FISHER SCIENTIFIC BIOTECH LINE ApS?
FISHER SCIENTIFIC BIOTECH LINE ApS most recently used PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB.
When was FISHER SCIENTIFIC BIOTECH LINE ApS founded?
FISHER SCIENTIFIC BIOTECH LINE ApS was founded on 27 May 1998.
What is the equity of FISHER SCIENTIFIC BIOTECH LINE ApS?
Equity was DKK 21.0m according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.